GLP-3 "RET" · 20MG
20MG research vial of retatrutide-class tri-agonist peptide for extended investigational studies.
These products are sold strictly for in-vitro laboratory research and are not intended for human consumption, diagnosis, treatment, or any therapeutic use. Purchaser must be 18 years of age or older and confirms they are a qualified researcher.
20MG research vial of retatrutide-class tri-agonist peptide for extended investigational studies. All ENOS research vials are lyophilized, sealed under sterile conditions, and shipped with cold-chain packaging where appropriate. A downloadable Certificate of Analysis is available on request for every batch.
You may also like
GLP-3 "RET" · 10MG
Next-gen tri-agonist studied for metabolic modulation.
BPC-157 · 10MG
Synthetic pentadecapeptide studied for tissue repair and GI healing.